Literature DB >> 3610389

Tumorigenicity of inorganic arsenic compounds following intratracheal instillations to the lungs of hamsters.

A Yamamoto, A Hisanaga, N Ishinishi.   

Abstract

The tumorigenicity of arsenic trioxide (As2O3), calcium arsenate (Ca3(AsO4)2) and arsenic trisulfide (As2S3) was studied in male Syrian golden hamsters which received arsenic compounds containing a total dose of 3.75 mg arsenic by means of intratracheal instillations once a week for 15 weeks. As controls, some hamsters were treated with only the vehicle, phosphate buffer solution. During the animals' total life span, one lung adenocarcinoma was seen in the 17 hamsters in the As2O3 group, one lung adenocarcinoma and 6 lung adenomas in the 25 hamsters in the Ca3(AsO4)2 group, one lung adenoma in the 22 hamsters in the As2S3 group and one lung adenosquamous carcinoma in the 21 hamsters in the control group. From these results, we conclude that calcium arsenate is tumorigenic to the lungs of Syrian golden hamsters. The results concerning the other 2 arsenic compounds were not conclusive.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3610389     DOI: 10.1002/ijc.2910400216

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Arsenic exposure and toxicology: a historical perspective.

Authors:  Michael F Hughes; Barbara D Beck; Yu Chen; Ari S Lewis; David J Thomas
Journal:  Toxicol Sci       Date:  2011-07-12       Impact factor: 4.849

Review 2.  Cancer in experimental animals exposed to arsenic and arsenic compounds.

Authors:  Erik J Tokar; Lamia Benbrahim-Tallaa; Jerrold M Ward; Ruth Lunn; Reeder L Sams; Michael P Waalkes
Journal:  Crit Rev Toxicol       Date:  2010-11       Impact factor: 5.635

3.  Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite.

Authors:  Jie Liu; Yuanfu Lu; Qin Wu; Robert A Goyer; Michael P Waalkes
Journal:  J Pharmacol Exp Ther       Date:  2008-05-07       Impact factor: 4.030

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.